Health Care Equipment
More
-
Cramer’s convinced the best way to for this health care company to maximize shareholder value is to break up.
-
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.
-
April 25- Medical device maker Boston Scientific Corp reported better-than-expected first-quarter results on Thursday, which the company said will put it on the path to return to growth. Boston Scientific's operating margin was considerably better than a year ago, Morningstar analyst Debbie Wang said.
-
Edwards said that first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc. Net income rose to $144.9 million, or $1.24 per share, from $65.1 million, or 55 cents per share, a year ago.
-
Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.
-
If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.
-
The number of complications from robot-assisted surgery using Intuitive Surgical's da Vinci robot are underreported, allege critics of the procedure, fanning the controversy around the company's pioneering product.
-
Intuitive Surgical's da Vinci robot was once hailed as a revolution in the operating room, but as more reports of complications have come to light, the da Vinci debate is heating up.
-
CHICAGO, April 17- In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from Siemens designed to light up brain deposits of tau, an Alzheimer's protein linked with cell death. Terms of the deal with the conglomerate's Siemens Medical Solutions USA unit were not disclosed.
-
April 17- Medical device maker St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell. First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.
-
April 17- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
-
CHICAGO, April 17- In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from Siemens designed to light up brain deposits of tau, an Alzheimer's protein linked with cell death. Terms of the deal with the conglomerate's Siemens Medical Solutions USA unit were not disclosed.
-
*Cook County jury awards no damages to plaintiff Carol Strum. April 16- An Illinois jury on Tuesday found in favor of Johnson& Johnson's DePuy orthopedics unit in a second product liability lawsuit over the company's recalled ASR metal hip implant to go to trial, J&J said.
-
April 10- St. Jude Medical Inc said on Wednesday it received European regulatory approval for a brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
-
April 10- St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
-
The FDA said its proposal would require manufacturers to provide clinical data or other evidence proving their devices are safe and effective in order to be approved or remain on the market. The proposals would also require manufacturers to provide inspection reports and submit to the FDA details of any changes made to the device.
-
WASHINGTON, March 22- A U.S. appeals court ruled on Friday that the Food and Drug Administration acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc..
-
March 22- The U.S. Food and Drug Administration is proposing new rules that would require makers of emergency defibrillator systems to conduct clinical trials before receiving marketing approval. The FDA plans to announce its proposed rules later today. The proposal was published on Friday morning in the Federal Register.
-
WASHINGTON, March 22- A U.S. appeals court ruled on Friday that the Food and Drug Administration acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc.
-
The FDA said its proposal would require manufacturers to provide clinical data or other evidence proving their devices are safe and effective in order to be approved or remain on the market. The proposals would also require manufacturers to provide inspection reports and submit to the FDA details of any changes made to the device.
Most Popular Video
DuckDuckGo CEO Gabriel Weinberg says web traffic on his search engine, billed as an alternative to Google that doesn't store your private information, surged 33 percent after the NSA news broke. Weinberg discusses the model of his search engine, and how the company makes money.
Wednesday, 19 Jun 2013 | 6:31 AM ETJohn Silvia, Wells Fargo Securities, and Barbara Marcin, Gabelli Dividend Income Fund, discuss whether investors should reconsider allocating their portfolios as the Fed wraps up its two-day policy meeting.
Wednesday, 19 Jun 2013 | 8:53 AM ETKen Langone, Invemed Associates chairman and president, called Fed Chairman Ben Bernanke a "lame duck."